GARBSEN, GERMANY / ACCESSWIRE / February 5, 2024 / ARRALYZE®, the Life Science arm of LPKF Laser & Electronics SE, proudly announces the commercial availability of the CellShepherd®. After a successful beta-testing phase in 2023, this groundbreaking platform is now ready to revolutionize cell-based research and development across biomedical and various life science fields.
CellShepherd®: Redefining Single-Cell Analysis CellShepherd®, developed by ARRALYZE®, responds to the urgent need for advanced functional cell screening technologies in academic and industrial laboratories. It stands out with ARRALYZE’s proprietary nanowell glass arrays, which miniaturize cell-based assays while enabling real-time monitoring at the single-cell level. This autonomous platform boasts precise dispensing into nanoliter glass wells and supports (co)-culturing under climate-controlled, sterile conditions. Its capabilities extend to real-time imaging through a brightfield microscope and three fluorescent channels. Leveraging advanced AI-driven analysis, CellShepherd® accurately counts and tracks cells, offering vital insights into various parameters. This innovation promises a new era in scientific research characterized by precision, control, and deep insights.
Meeting Market Demands: The ARRALYZE® Vision CellShepherd® is designed to fulfill the growing demand for technologies capable of studying small and large cell populations at the single-cell level and isolating target cells. By adopting a holistic approach, ARRALYZE® enables customers to uncover individual characteristics of heterogeneous cell populations and gain insight into the kinetics of experiments, monitoring functionality at different time points. This approach overcomes challenges such as harsh experiment conditions, limited microenvironment control, and difficulties maintaining cell viability.
Key Features and Benefits
Proprietary nanowell glass arrays for precise miniaturization of cell-based assays.
Precise dispensing of cell suspensions with outstanding viability.
Autonomous operation supporting (co)-culturing in a climate-controlled, sterile environment.
Advanced real-time imaging capabilities including a brightfield microscope and three fluorescent channels.
AI-driven analysis for accurate cell counting and tracking.
User-friendly interface designed for ease of experiment setup, monitoring, and analysis.
Ability to isolate live cells for downstream processes, enhancing versatility and application scope.
About LPKF LPKF Laser & Electronics SE, the parent company of ARRALYZE, is a leading provider of laser-based solutions for the technology industry. Founded in 1976, the company is headquartered in Germany, and is active worldwide through subsidiaries and representatives. The establishment of ARRALYZE as a dedicated division signifies LPKF’s commitment to innovation and excellence in the biotechnological sector. LPKF Laser & Electronics SE shares are traded in the Prime Standard segment of Deutsche Börse (ISIN 0006450000).
Contact For more information about CellShepherd® and ARRALYZE®, please visit www.arralyze.com or contact us by email at info@arralyze.com
ARRALYZE is part of LPKF group: LPKF Laser & Electronics SE Osteriede 7 D-30827 Garbsen Fon: +49 (0) 5131 7095-0 Fax: +49 (0) 5131 7095-90 www.lpkf.com
VICTORIA, BC / ACCESSWIRE / February 5, 2024 / Boron One Holdings Inc. ("Boron One" or the "Company") (TSXV:BONE), a company dedicated to the decarbonization of Planet Earth through the responsible utilization of its boron assets, is pleased to report that it has been granted a new exploration license by the Serbian Ministry of Mining and Energy for the Company’s wholly owned Piskanja Boron Project. This new 3-year license ensures Boron One’s continued exclusive rights to the Piskanja property, as the Company progresses through the mineral exploitation approval process for Piskanja (the "Approval Process") with the Mining Ministry. As previously reported by the Company, it has received a "Certificate of Reserves" from the Mining Ministry as the first requisite step in the Approval Process, and is readying the mandatory documentation for submission in order to receive the "Approval of the Exploitation Field" as the next step in the Approval Process.
Tim Daniels, CEO of Boron One added, "Requesting a new exploration license was prudent to ensure continuity in our exclusive rights to the Piskanja deposit while we are in process to complete the exploitation licensing procedure. Our original Piskanja exploration license had expired, but exclusive exploitation rights do not commence until we receive an Approval of the Exploitation Field from the Ministry, prompting this interim action to ensure our uninterrupted rights to Piskanja between those two events." Tim Daniels continued, "Additionally, this new exploration license affords us an opportunity to attempt to expand the extent of the known mineral resource at Piskanja, as there remain unexplored regions of the property that lie outside the currently known mineral body footprint, but within the boundaries of the Piskanja exploration license area."
About the Piskanja Boron Project
Piskanja is Boron One Holdings Inc.’s wholly owned boron deposit with a Measured Mineral Resource of 1.39 million tonnes (averaging 35.59% B2O3), an Indicated Mineral Resource of 5.48 million tonnes (averaging 34.05% B2O3), and an Inferred Mineral Resource of 284.7 thousand tonnes (averaging 39.59% B2O3), calculated in accordance with the Canadian Institute of Mining Definition Standards on Mineral Resources and Reserves (CIM Standards), as disclosed in the Company’s report titled, "Technical Report and Preliminary Economic Assessment For The Piskanja Borate Project, Serbia, June 24, 2022". The responsible person for the PEA and the Mineral Resource Estimate contained within, is Prof. Miodrag Banješević PhD. P.Geo, EurGeol, a Qualified Person in accordance with the CIM Definition Standards on Mineral Resources and Reserves (CIM Standards), and independent of Boron One Holdings Inc.
On behalf of the Board of Directors, Tim Daniels
About Boron One Holdings Inc. (formerly known as Erin Ventures Inc.)
Boron One Holdings Inc. is a leading company dedicated to advancing the decarbonization of our planet through the responsible utilization of its wholly owned boron assets. With a commitment to environmental stewardship and sustainability, Boron One aims to play a crucial role in reducing the carbon footprint and supporting a cleaner, greener future.
Headquartered in Victoria, B.C., Canada, Boron One’s shares are traded on the TSX Venture Exchange under the symbol "BONE". For detailed information please see Boron One’s website at www.boronone.com or the Company’s filed documents at https://www.sedarplus.ca/.
For further information, please contact: Boron’s Public Quotations:
Nenad Rakic, EurGeol, Piskanja Project Field Manager, a qualified person as defined by NI 43-101, has reviewed the technical information that forms the basis for this news release, and has approved the disclosure herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For Boron One Holdings Inc. Investors
Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, Boron One’s expectations concerning management’s plans, objectives and strategies, including its plans for advancing the Company’s Piskanja Project through to an exploitation license. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, failure to convert estimated mineral resources to reserves, capital and operating costs varying significantly from estimates, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and the other risks involved in the mineral exploration and development industry.
Boron One Holdings Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by Boron One with the securities regulatory authorities, available at www.sedar.com. These and other factors made in public disclosures and filings by the Company should be considered carefully.
Mineral resources are not mineral reserves and do not have demonstrated economic viability. "Inferred Resources" have a great amount of uncertainty as to their existence, and economic and legal feasibility. Investors are cautioned not to assume that all or any part of an inferred mineral resource reported in this news release will ever be upgraded to a higher category or to reserves. U.S. persons are advised that while mineral resources are recognized under Canadian regulations, the U.S. Securities and Exchange Commission does not recognize them. U.S. persons are also cautioned not to assume that all or any part of an inferred mineral resource is economically or legally mineable.
By webcast — Log on to the web at the address above
By phone — please call (866) 373-3416
Contact:
Gladstone Investment Corporation, (703) 287-5893
A conference call replay will be available beginning one hour after the call and will be accessible through February 14, 2024. To hear the replay, please dial (877) 660-6853 and use playback conference number 13742735.
If you are unable to participate during the live webcast, the call will be archived on the website www.gladstoneinvestment.com. The event will be archived and available for replay on the Company’s website.
Gladstone Investment Corporation is a publicly traded business development company that seeks to make secured debt and equity investments in lower middle market businesses in the United States in connection with acquisitions, changes in control and recapitalizations.
For further information: Gladstone Investment Corporation, (703) 287-5893
The PROTALITY brand provides nutritional support for adults pursuing weight loss in the form of a high-protein nutrition shake featuring a blend of fast- and slow-digesting protein designed to feed muscles for up to seven hours
As people eat less and lose weight, a portion of what’s lost may be from muscle, which is vital to overall health and physical functioning
More than 7 in 10 adults are overweight or have obesity in the U.S. and many turn to diets, whether combined with medication, surgery or calorie restriction, to lose weight and improve overall health1
Abbott (NYSE:ABT), a global leader in science-based nutrition, announced today the launch of its new PROTALITY brand. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.
Losing weight is a complex and personal process. Nearly half of U.S. adults attempted to lose weight in the past year.2 Whether pursuing weight loss by taking GLP-1 medications, undergoing a weight-loss surgery or following a calorie-restricted diet,3,4,5 people risk losing 11-50 percent muscle6,7,8 which plays an integral role in daily activities, movement and energy metabolism. Protein can help preserve muscle as people lose weight.
To preserve muscle mass during weight loss, research shows adults may need at least 50 percent more protein than the Recommended Dietary Allowance (RDA).9,10,11,12 High protein consumption can also support weight loss maintenance.13,14,15,16
”It’s critical for adults on weight loss regimens to prioritize good nutrition to ensure they get enough micronutrients and protein to preserve muscle mass while consuming limited calories,” said Hakim Bouzamondo, MD, MSC, MBA, division vice president of Nutrition Research and Development at Abbott. ”We’ve studied muscle health and nutrition for decades at Abbott. We understand that a weight loss journey can be challenging, which is why we’re launching the PROTALITY brand to give adults nutritional products with an excellent source of high-quality protein and nutrients to support muscle health.”
The Importance of Preserving Muscle During Weight Loss There are more than 650 muscles in the human body. Muscles help support daily activities, movement and energy metabolism. Protein is an important building block for muscles, as well as skin, tissue and bones, and plays a vital role in metabolism, satiety and weight maintenance.
”We’ve learned from people on weight loss journeys – including those on GLP-1 medications – that they experience decreased appetite and thoughts of food,” said Dominique R. Williams, MD, MPH, medical director and obesity specialist at Abbott. ”Whether it’s due to decreased appetite or a busy schedule, it can be difficult for people losing weight to get the protein, vitamins and minerals they need to support their unique health goals. Our PROTALITY brand provides a nutrient-dense option designed to address gaps that may result in their diets.”
Targeted Nutrition to Feed Muscles and Busy Lifestyles PROTALITY is a new brand created for people pursuing weight loss. The first product available is a high-protein nutrition shake for people who may have difficulty getting enough protein and other essential nutrients to support muscle mass and function. The formulation is equivalent to the nutrition in Abbott’s successful Ensure® Max Protein drink and will serve as a base to continue further innovations under the brand.
”We’re serving a new group of people who may be at a higher nutritional risk because they may be overweight or have obesity and use weight loss medications,” said Bouzamondo. ”Abbott intends to develop additional science-backed nutrition products and conduct clinical research to address the targeted nutrition needs of people losing weight.”
Each PROTALITY shake has key nutrients to support weight loss journeys:
30 grams of high-quality protein to help preserve muscle
8 essential B vitamins for protein and energy metabolism
4 grams of comfort fiber for digestive health
1 gram of sugar
150 calories
25 vitamins and minerals
”As people start to see results from their weight loss programs, many look for ways to maintain progress, including their nutrition goals,” added Williams. ”Whether that’s planning meals or snacks, they are looking for nutritious, easy protein options like PROTALITY that work with their busy schedules and support their personal nutrition goals.”
Individuals on a weight loss journey should always discuss their nutritional plan with their healthcare provider.
PROTALITY Availability Online and at Retailers
PROTALITY joins Abbott’s trusted portfolio of adult nutrition products that includes Ensure® and Glucerna®.
The new shake comes in Milk Chocolate and Vanilla flavors in 11-ounce, four-pack units. PROTALITY is now available at Amazon.com, Walmart.com and Kroger.com and coming to stores including Kroger, ShopRite (February), Albertsons (March), CVS (March), Walmart (April), Publix (April), and Meijer (May).
Visit PROTALITYNutrition.com to learn more and follow us on Instagram @PROTALITY_US and Facebook @PROTALITYUS.
About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
1 Fryar CD, Carroll MD, et al. NCHS Health E-Stats, Centers for Disease Control and Prevention. 2020. Updated Feb. 8, 2021.
2 Centers for Disease Control and Prevention. NCHS Data Brief No. 313, July 2018.
3 Chaston TB, et al. Int J Obes (Lond). 2007;31(5):743-750.
4 Pownall HJ, et al. Obesity (Silver Spring). 2015;23(3): 565-572.
5 Sargeant JA, et al. Endocrinol Metab (Seoul). 2019;34(3): 247-262.
6 Chaston TB, et al. Int J Obes (Lond). 2007;31(5):743-750.
7 Pownall HJ, et al. Obesity (Silver Spring). 2015;23(3):565-572.
8 Sargeant JA, et al. Endocrinol Metab (Seoul). 2019;34(3): 247-262
9 Kim JE, et al. Nutr Rev. 2016;74:210-224.
10 Soenen S, et al. J Nutr. 2013;143:591-596.
11 Layman DK, et al. J Nutr. 2003;133:411-417.
12 Leidy HJ, et al. Obesity. 2007;15:421-429.
13 Drummen, M. et al. Study. J Nutr.2020;150:458-463.
14 Leidy, H.J. et al. Obesity2007;15:421-429.
15 Lejeune, M.P. et al. Br J Nutr.2005;93:281-289.
16 Claessens, M. et al. Int J Obes (Lond).2009;33:296-304.
For further information: Abbott Media: Michelle Schott, (614) 286-4727; Rachel Bassler, (224) 441-0470; Abbott Financial: Ryan Aliff, (224) 234-4228
INTRODUCING PROTALITY – FOR PEOPLE ON WEIGHT LOSS JOURNEYS The makers of Ensure, the #1 doctor-recommended brand, introduce a nutrition shake that provides targeted nutrition for muscle health and helps support nutrition goals during weight loss.
LOS ANGELES, CA / ACCESSWIRE / February 5, 2024 / The Ohana, a world-class detox and residential inpatient treatment program, announces plans for expansion in 2024. In response to unprecedented demand for its services, The Ohana will be adding four additional beds to its Hawaii location, enhancing its capacity to provide personalized care and support to individuals on their journey to recovery. The ownership group of The Ohana is also set to open a second location in California by the end of Q2 2024, extending its renowned treatment program to a new market.
The Ohana offers resort-style detox and addiction treatment rehabilitation services. A hallmark of the treatment plan is exposing clients to the magical surroundings unique to Hawaii.
Founder Elliott Michael Smith was drawn to Hawaii when he sought treatment for himself years ago. Finding there were no evidence-based high-end options on the islands, he committed to creating one. In 2020, he fulfilled his promise when The Ohana, the first world-class, luxury drug and alcohol rehab center in Hawaii, opened its doors.
At The Ohana, clients have access to a comprehensive range of medical & clinical services designed to address their physical and mental health needs. These services include psychiatric evaluations, medication management, EMDR therapy, psychodynamic therapy, and a robust supportive family program.
Clients also enjoy luxurious spa treatments, such as massage and acupuncture, as well as holistic practices like yoga and meditation. Nutritious meals prepared by a gourmet chef ensure that clients receive the nourishment they need to thrive.
The Ohana also offers one-of-a-kind adventure therapy activities that take advantage of the majestic Hawaiian location. Therapeutic adventures such as snorkeling, hiking, and ocean boat tours provide opportunities for teamwork, personal growth, and self-discovery.
In late 2024, The Ohana will expand from 8 residential client capacity to 12. The expansion is a result of the high demand for the services. Smith is excited that the expansion means that they can help more clients, without sacrificing the intimacy of their one-on-one customized care.
"Our mission at The Ohana is comprehensive, compassionate, and evidence-based addiction treatment services that empower individuals and families on their journey to lasting recovery," says Smith. "With our expansion plans, we are committed to reaching more people in need and continuing to set the standard for excellence in addiction treatment and recovery support."
The group behind The Ohana, led by Smith, will open a California location. Like The Ohana, the new location will take advantage of its desert location as a therapeutic focus.
The group seeks out locations that have a spiritual component, like Hawaii and the California desert. They believe that location and the activities afforded are an integral part of healing.
Since its opening, The Ohana has become a beacon of hope and transformation for individuals seeking recovery from addiction and mental health challenges. Founded by Smith, a veteran of the entertainment industry, The Ohana offers a unique approach that combines evidence-based modalities with holistic and adventure therapy. With Joint Commission Accreditation, State Licensing, and State Accreditation, The Ohana is Hawaii’s top-rated program, known for its commitment to providing compassionate and effective evidence-based clinical care.
As The Ohana looks towards the positive changes in 2024, it remains dedicated to inspiring positive change in the lives of those affected by addiction, offering hope, healing, and a path to a brighter, healthier future.
For more information about The Ohana and its expansion plans, please visit www.theohanahawaii.com.
FAIRFIELD, NJ / ACCESSWIRE / February 5, 2024 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company’s common stock. The dividend is payable on or about February 23, 2024 to the stockholders of record as of February 16, 2024.
About Jerash Holdings (US), Inc.
Jerash Holdings (US), Inc. manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands and retailers, including VF Corporation (which owns brands such as The North Face, Timberland, and Vans), New Balance, G-III (which licenses brands such as Calvin Klein, Tommy Hilfiger, DKNY, and Guess), American Eagle, and Skechers. Jerash’s existing production facilities comprise six factory units and four warehouses, and Jerash currently employs approximately 5,000 people. Additional information is available at www.jerashholdings.com.
# # #
Contact:
PondelWilkinson Inc. Judy Lin or Roger Pondel 310-279-5980 jlin@pondel.com
SSB Bancorp, Inc. Reports Unaudited Consolidated Financial Results For the year ended December 31, 2023
PITTSBURGH, PA / ACCESSWIRE / February 5, 2024 / SSB Bancorp, Inc. (OTC PINK:SSBP – news) (the "Company"), the holding company for SSB Bank (the "Bank"), today announced the Company’s unaudited, consolidated results of operations for the year ended December 31, 2023.
Total assets increased $44.6 million to $295.8 million at December 31, 2023, from $251.2 million at December 31, 2022. The increase in assets was due to an increase in deposits of $38.2 million as well as a net increase in Federal Home Loan Bank advances of $1.0 million. These funding increases were converted into a net increase of $31.2 million in net loans, $10.2 million in certificates of deposit, and $1.1 million in interest-bearing deposits with other financial institutions.
For the year ended December 31, 2023
Net earnings for the year ended December 31, 2023, was $1.9 million, or $0.88 per basic and diluted share, compared to net earnings of $1.3 million, or $0.62 per basic and diluted share, for the year ended December 31, 2022.
Total interest and fee income increased by $4.1 million, or 41.0%, when comparing the results of the year ended December 31, 2023, to the year ended December 31, 2022. This is due to the increase in yield of interest-earning assets from 4.48% to 5.22% as well as an increase in average interest-earning assets of $47.3 million when comparing the two periods.
Interest expense increased by $3.4 million, or 119.4%, to $6.2 million in the year ended December 31, 2023, from $2.8 million in the year ended December 31, 2022. The increase in interest expense is due to the increase in cost of interest-bearing liabilities from 1.41% for the year ended December 31, 2022, to 2.99% for year ended December 31, 2023. This increase in cost is due to the increase in market interest rates when comparing the two periods. Additionally, average interest-bearing liabilities increased by $7.3 million from $199.2 million for the year ended December 31, 2022, to $206.5 million for the year ended December 31, 2023.
Noninterest income increased by $848,000, or 69.3%, to $2.1 million from $1.2 million when comparing the year ended December 31, 2023, to the year ended December 31, 2022. The increase is due to the increase in credit card processing fees of $798,000 when comparing the two periods. The credit card processing portfolio continues to grow in both the number of merchants as well as the volume of transactions settled.
Noninterest expense increased by $479,000 or 7.4% to $6.9 million. This was mainly due to increases in salaries and employee benefits of $155,000, outside professional fees of $127,000, and federal deposit insurance of $59,000, when comparing the two periods. These increases were offset by a decrease in marketing expense. The decrease in marketing fees reflects a change in business development methods with a higher emphasis on business development through referral of existing business channels.
This release may contain forward-looking statements within the meaning of the federal securities laws. These statements are not historical facts; rather, they are statements based on the Company’s current expectations regarding its business strategies and their intended results and its future performance. Forward-looking statements are preceded by terms such as "expects", "believes", "anticipates", "intends" and similar expressions.
Forward-looking statements are not guarantees of future performance. Numerous risks and uncertainties could cause or contribute to the Company’s actual results, performance and achievements to be materially different from those expected or implied by the forward-looking statements. Factors that may cause or contribute to these differences include, without limitation, general economic conditions, including changes in market interest rates and changes in monetary and fiscal policies of the federal government; legislative and regulatory changes.
Because of the risks and uncertainties inherent in forward-looking statements, readers are cautioned not to place undue reliance on them, whether included in this report or made elsewhere from time to time by the Company or on its behalf. The Company assumes no obligation to update any forward-looking statements.
TORONTO, ON/ ACCESSWIRE / February 5, 2024 / Adcore Inc. (the "Company" or "Adcore") (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ), a leading e-commerce advertising management and automation platform to leverage digital marketing in an effortless and accessible way ("Effortless Marketing"), today announced the renewal of its channel partner agreement with Microsoft Advertising for 2024, further cementing its position as a key player in digital marketing. This renewal comes on the heels of the company being honored as the Global Partner of the Year for 2023 by Microsoft Advertising, a testament to its exceptional performance and innovation in the field. Since joining the Microsoft Advertising Partner Program in September 2019, Adcore has consistently demonstrated excellence, earning the esteemed Microsoft Elite Partner status in February 2022. This accolade recognizes the Company’s superior technological solutions and its effective strategies in attracting unique advertisers to Microsoft Advertising.
Omri Brill, CEO of Adcore, commented, "The renewal of our partnership with Microsoft for 2024 isn’t just a continuation; it’s a pivotal moment that aligns with our focus for the year ahead. Following our accolade as Microsoft’s 2023 Advertising Global Channel Partner of the Year and building upon our 2022 recognition for the EMEA region, we are setting our sights even higher for 2024. Our strategy is laser-focused on driving new business towards Microsoft and growing top-of-funnel activities on the Microsoft Audience Network and Connected TV, including leveraging exclusive assets that Microsoft offers, such as Netflix advertising. This partnership has consistently empowered us to enhance our offerings and deliver substantial value to our clients, helping them to broaden their digital advertising horizons."
Nigel Leggatt, Director of Partner Sales – EMEA at Microsoft, "I’m delighted with the continued success of our channel partnership with Adcore. Their international growth and diverse client base across multiple industries have been remarkable, benefiting greatly from the integration of Microsoft Advertising products into Adcore’s Marketing Cloud solutions. The synergy between our companies has been a driving force, creating substantial value. As we enter the fifth year of our collaboration, the positive feedback from Adcore’s clients highlights the tangible results and future growth opportunities of this partnership. Adcore has become a key partner, and we’re excited about the potential our future collaboration holds."
ABOUT ADCORE
Adcore is a leading AI-powered marketing and online learning technology company.
By combining extensive industry knowledge and experience with its proprietary artificial intelligence (AI) powered technology, Adcore offers a unique digital marketing solution that empowers entrepreneurs and advertisers by managing and automating their e-commerce store advertising and monitoring and analyzing the performance of their advertising budget to ensure maximum Return on Investment. Adcore is a certified Google Premier Partner, Elite Tier Microsoft Partner, Facebook Partner and TikTok Partner.
Adcore also runs Amphy, the world’s most diverse 24/7 live online learning marketplace. Learners can choose from thousands of classes across hundreds of categories to grow their passions, skills and expand their children’s learning opportunities. Instructors on the Amphy platform join a vibrant virtual teacher community that promotes and supports their success through enrichment seminars, marketing and advertising, and a suite of tools that allow them to run their classes hassle-free and focus on their students. Amphy students gain access to high-quality, personalized classes that are accessible 24/7, while joining a growing community of lifelong learners.
Established in 2006, the Company employs over fifty people in its headquarters in Tel Aviv, Israel and satellite offices in Toronto, Canada, Melbourne, Australia, Hong Kong and Shanghai, China.
This press release contains or may contain certain forward-looking statements, including statements about the Company. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
CHELMSFORD, MA / ACCESSWIRE / February 5, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for 100 years, today announced the appointment of two senior executives to newly-created roles reporting to Kelly Waller, Senior Vice President of Sales and Marketing.
Varsha Tomar was named Vice President, Partnerships, and will oversee the identification, cultivation, and management of strategic B2B sales partnerships that will enable Harte Hanks to drive incremental revenue. She will oversee joint alliances, resellers/white labelers of Harte Hanks services and manage a team of Inside Partner Account Managers. Ms. Tomar joins Harte Hanks from HealthEquity, where she was Director of Business Operations after previously serving as Global Head of Go-To-Market Strategy for Finastra.
Luke Kenny was named Sr. Director of International Sales and Client Expansion. Based in Portugal, Mr. Kenny has nearly two decades of experience as a sales director and demand generation expert across EMEA and APAC for B2B organizations, including Finastra and FIS. At Harte Hanks, he will focus on sales as well as supporting and growing business from existing European clients. He is also tasked with overseeing the growth of the sales teams throughout the region. Harte Hanks has offices in the UK, Romania and Belgium.
"As we continue to implement our transformation growth plan, these two strategic hires will help us meet our goals of expanding our sales and marketing organization routes to market and expanding our global footprint," commented Ms. Waller.
About Harte Hanks:
Harte Hanks (NASDAQ:HHS) is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract and engage their customers.
Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world’s premier brands, including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Chelmsford, Massachusetts, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.
As used herein, "Harte Hanks" or "the Company" refers to Harte Hanks, Inc. and/or its applicable operating subsidiaries, as the context may require. Harte Hanks’ logo and name are trademarks of Harte Hanks.
Certain statements discussed in this release as well as in other reports, materials and oral statements that the Company releases from time to time to the public may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Generally, words such as "anticipate," "estimate," "expect," "project," "intend," "believe," "plan," "target," "forecast" and similar expressions are intended to identify forward- looking statements. Such forward-looking statements concern management’s expectations, strategic objectives, business prospects, anticipated economic performance and financial condition and other similar matters. Forward-looking statements are inherently uncertain and subject to a variety of assumptions, risks and uncertainties that could cause actual results to differ materially from those anticipated or expected by the management of the Company. These statements are not guarantees of future performance and actual events or results may differ significantly from these statements. Given these risk factors, investors and analysts should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of the document in which they are made. The Company disclaims any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in the Company’s expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, except as required by law. It is advisable, however, to consult any further disclosures the Company makes in its filings with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (if any). These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995.
The long-awaited Dr. Serkan Aygin Clinic’s Miami branch office is now available for free consultations
MIAMI, FL / ACCESSWIRE / February 5, 2024 / The world-famous Dr. Serkan Aygın, a pioneer in the hair transplantation realm, has opened a new branch office for his eponymous clinic in downtown Miami. Floridians dealing with hair loss can now visit the award-winning clinic in the Magic City to get a free consultation and schedule their life-changing surgery in Turkey.
Miami Branch Office – Dr. Serkan Aygin Dr. Serkan Aygin Clinic’s Miami branch office is now available for free consultations
Top-Notch Hair Transplant Results
Ahair transplant in Turkey has become synonymous with world-class results at a fraction of the price. Turkish clinics have patient-oriented medical teams focusing on service quality, satisfaction, and safety and following the highest industry standards. Dr. Serkan Aygın Clinic is no exception.
Famous for natural-looking results, it helps patients wave hair loss goodbye and welcome thick, dense hair that transforms their appearance. Dr. Serkan Aygın has 25+ years of experience, counting 10,000+ satisfied patients who enjoy a 98% hair regrowth rate.
His contributions to the field have brought him many accolades, including Europe’s Best Hair Transplant Surgeon Award at the 2019 European Awards in Medicine. His clinic has also received recognition, including the Best Medical Tourism Facility Award at the 2019 Tourism Awards by VD Viajes’ La Razón in Spain.
Cutting-Edge Hair Transplant Methods
Dr. Serkan Aygın Clinic specializes in innovative hair transplant methods, including Sapphire FUE (Follicular Unit Extraction) and DHI (Direct Hair Implantation). The former addresses extensive hair loss, while the latter suits patients with mild-to-moderate baldness.
Both techniques ensure high precision, minimize scalp trauma, reduce healing time, and provide natural-looking results. However, the DHI method is the upgraded version that helps achieve higher graft survival and density and doesn’t require shaving the head.
It uses a Choi pen for extracting and directly implanting hair grafts without previous incisions. Besides eliminating scarring, it enables surgeons to insert follicles at the correct angles, ensuring transplanted hair matches natural hair.
Constant Innovation
Dr. Serkan Aygın Clinic doesn’t take a one-size-fits-all approach to hair transplantation. It offers personalized services to meet every patient’s needs and expectations. One includes 3D technology for analyzing hair and taking measurements for pre-operative planning.
The award-winning Doku Studio Arc, the clinic’s device for 3D hair analysis, creates a 360° head model, takes photos from multiple angles and axes, and calculates the hair density, thickness, and strand number in roots. It provides accurate information for successful hair transplants.
Contact Information
Anyone considering a hair transplant in Turkey can contact or visit Dr. Serkan Aygın Clinic in Miami for a free consultation. The clinic is at 333 SE 2nd Ave Suite 2000 and is open Mondays through Fridays from 12 a.m. to 8 p.m.
brand provides nutritional support for adults pursuing weight loss in the form of a high-protein nutrition shake featuring a blend of fast- and slow-digesting protein designed to feed muscles for up to seven hours
